Jane Street’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-181,371
| Closed | -$181K | – | 10117 |
|
|
2023
Q3 | $181K | Buy |
181,371
+135,544
| +296% | +$104K | ﹤0.01% | 7694 |
|
|
2023
Q2 | $22.5K | Buy |
+45,827
| New | +$37.5K | ﹤0.01% | 8346 |
|
|
2023
Q1 | – | Sell |
-33,224
| Closed | -$89K | – | 10304 |
|
|
2022
Q4 | $89K | Buy |
33,224
+22,228
| +202% | +$58.6K | ﹤0.01% | 8156 |
|
|
2022
Q3 | $31K | Sell |
10,996
-31,587
| -74% | -$134K | ﹤0.01% | 9086 |
|
|
2022
Q2 | $211K | Buy |
42,583
+11,269
| +36% | +$59K | ﹤0.01% | 8126 |
|
|
2022
Q1 | $223K | Sell |
31,314
-26,415
| -46% | -$219K | ﹤0.01% | 8885 |
|
|
2021
Q4 | $1.05M | Buy |
57,729
+42,316
| +275% | +$913K | ﹤0.01% | 5801 |
|
|
2021
Q3 | $301K | Buy |
15,413
+2,360
| +18% | +$89.7K | ﹤0.01% | 8174 |
|
|
2021
Q2 | $585K | Sell |
13,053
-13,833
| -51% | -$641K | ﹤0.01% | 6947 |
|
|
2021
Q1 | $1.35M | Buy |
26,886
+18,045
| +204% | +$1.23M | ﹤0.01% | 4837 |
|
|
2020
Q4 | $790K | Buy |
+8,841
| New | +$744K | ﹤0.01% | 5046 |
|
Jane Street's CELL Position: Q4 2023 in Review
Jane Street sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 181,371 shares — an estimated $181K sold.
Jane Street first reported a position in CELL in Q4 2020 and held it in 11 quarters. The position peaked at $1.35M in Q1 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.
- Jane Street reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Jane Street sold 181,371 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $181K.
- Jane Street first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 11 quarters.
- Jane Street's PhenomeX Inc. Common Stock position peaked at $1.35M in Q1 2021.
- 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.
Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.